Compare · ILMN vs MOH
ILMN vs MOH
Side-by-side comparison of Illumina Inc. (ILMN) and Molina Healthcare Inc (MOH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and MOH operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $28.24B, about 2.4x MOH ($11.74B).
- MOH has been more active in the news (14 items in the past 4 weeks vs 11 for ILMN).
- Both have 25 recent analyst ratings on file.
- Company
- Illumina Inc.
- Molina Healthcare Inc
- Price
- -
- -
- Market cap
- $28.24B
- $11.74B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- 2003
- News (4w)
- 11
- 14
- Recent ratings
- 25
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Molina Healthcare Inc
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.
Latest ILMN
- Illumina expands Billion Cell Atlas program with new AI drug developers
- Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
- Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
- Director Meister Keith A. was granted 142 shares, increasing direct ownership by 2% to 6,780 units (SEC Form 4)
- Director Ullem Scott B. was granted 167 shares, increasing direct ownership by 2% to 11,030 units (SEC Form 4)
- Bernstein resumed coverage on Illumina with a new price target
- Chief Legal Officer Davies Scott M sold $110,700 worth of shares (615 units at $180.00), decreasing direct ownership by 3% to 20,953 units (SEC Form 4)
- Director Skovronsky Daniel was granted 1,674 shares (SEC Form 4)
- SEC Form 3 filed by new insider Skovronsky Daniel
- Illumina Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest MOH
- Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600
- Director Zoretic Richard C was granted 237 shares (SEC Form 4)
- Director Wolf Dale B was granted 237 shares (SEC Form 4)
- Director Schapiro Richard M was granted 237 shares, increasing direct ownership by 2% to 12,311 units (SEC Form 4)
- Director Romney Ronna was granted 237 shares (SEC Form 4)
- Director Orlando Steven J was granted 237 shares (SEC Form 4)
- Director Lockhart Stephen H was granted 237 shares, increasing direct ownership by 6% to 4,384 units (SEC Form 4)
- Director Grohowski Leo P was granted 237 shares, increasing direct ownership by 18% to 1,542 units (SEC Form 4)
- Director Soistman Francis S Jr was granted 237 shares, increasing direct ownership by 35% to 907 units (SEC Form 4)
- Director Brasier Barbara L was granted 237 shares, increasing direct ownership by 4% to 5,818 units (SEC Form 4)